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The author analyzed the annual trends in the number of deaths from nonmelanoma skin cancer (NMSC) from 1955 to 2008
in Japan on the basis of the data from the Vital Statistics of Japan. The general trends in the number of deaths from NMSC
were downward between 1979 to 1994, but upward after 1995. The general trends in age-standardized death rates were roughly
downward, although the death rates plateaued after 1995. The recent annual increased ratio of deaths from NMSC was 3.8% (95%
conﬁdence interval: 2.7∼4.9%). The number and proportion of deaths from NMSC among the elderly were increasing in Japan.
For females, more than 50% of the deaths occurred recently at or after 85years of age, whereas, for males, this proportion was at
or after 75years of age, nearly reaching at or after 80years of age.
1.Introduction
The incidence of nonmelanoma skin cancer (NMSC) has
been increasing during the past half century in many
countries [1–6]. Authors performed the analysis of changing
trends in the number of deaths from NMSC in Japan from
1955 to 2000 [7]. This time, the author expanded the period
of survey to 2008 and revised the analysis, using the new
WHO standard population which is eﬀective for the period
2000–2025 [8].
2.MaterialandMethods
The annual trends in the number of deaths from NMSC
in Japan from 1955 to 2008, those in age-standardized
death rates, those in 3-year moving average, those by 5-year
age group, those by sex and age group, and those in the
proportion of deaths by sex and age group were investi-
gated on the basis of the data from the Vital Statistics of
Japan, Statistics and Information Department, Minister’s
Secretariat, Ministry of Health, Labor and Welfare.
The corresponding revisions of the International Clas-
siﬁcation of Diseases (ICD) and codes were ICD-6 code
191 in 1955–1957, ICD-7 code 191 in 1958–1967, ICD-8
code 173 in 1968–1978, ICD-9 code 173 in 1979–1994, and
ICD-10 code C44 in 1995–2008, respectively. The author,
however, treated the results continuously from 1955 to 1967,
because there was no diﬀerence between ICD-6 and ICD-
7 concerning NMSC. The author treated the remaining
revisions as discontinuous, because there was a minor
diﬀerence between ICD-6/-7, ICD-8, ICD-9, and ICD-10.
The author judged that it would be possible to obtain the
general annual trends in the number of deaths from NMSC
in Japan for 54 years, although, strictly speaking, there were
four times minor changes of ICD classiﬁcations concerning
NMSC between these periods.
The death rates were adjusted every year using the new
WHO world standard population which is eﬀective for the
period 2000–2025. The 3-year moving averages of changes
in the number of deaths were calculated in the periods
of 1955–1967, 1968–1978, 1979–1994, and 1995–2008 in
accordancewiththefollowing:{(n2+n3+n4)/3−(n1+n2+
n3)/3}/(n1+n2+n3)/3, where n indicated the number of
deaths in each year. Thereafter, the annual increased ratio in
each period was deﬁned as the averages of the 3-year moving
ones.2 Journal of Skin Cancer
3. Results
The general trends in the number of deaths from NMSC
were downward between 1979 and 1994, but upward after
1995 (Figure 1). There was no gender diﬀerence in mortality.
The general trends in age-standardized death rates were
roughly downward, although the death rates plateaued after
1995 (Figure 2). The age-standardized death rate per 100,000
population in 2008 was 0.201 (0.103 in males, 0.098 in
females). The annual increased ratio of deaths from NMSC
from the 3-year moving increased ratio was 0.0% (95%
conﬁdence interval, CI: −1.4∼1.4%) in 1955–1967, −0.1%
(CI: −1.8∼1.6%) in 1968–1978, −0.8% (CI: −2.0∼0.4%)
in 1979–1994 and 3.8% (CI: 2.7∼4.9%) in 1995–2008,
respectively(Figure3).Theratioinmalesandfemalesineach
revision is shown in Table 1. The number and proportion of
deaths among the elderly were increasing (Figures 4, 5,a n d
6). The peak age group of deaths was roughly the seventies
in 1955–1979 and the eighties after 1980. However, there was
ag e n d e rd i ﬀerence, as might be expected from the greater
longevity of women. That is, there was a tendency of a
sharperincreaseinthedeathratiowithageinfemalesthanin
males (Figure 6). For females, more than 50% of the deaths
occurred recently at or after 85 years of age, whereas, for
males, this proportion was at or after 75 years of age, nearly
reaching at or after 80 years of age.
4. Discussion
According to Jemal et al. [9], greater than 2 million cases of
basal cell carcinoma (BCC) and squamous cell carcinoma
(SCC) were expected to be newly diagnosed in the USA
in 2010. Approximately 80% of NMSCs are also said to
be BCCs and 20% SCCs [2, 10]. Stratton [11]d e s c r i b e d
that NMSC received a disproportionate share of attention
because mortality was relatively low. Cutaneous SCCs are,
however, associated with a substantial risk of metastasis,
unlike almost all BCCs [2]. Consequently, SCC is considered
to be the main cause of death in NMSCs. The population-
based case-fatality rates for BCC and SCC were estimated
to be roughly 0.05% and 0.7%, respectively by Weinstock
in 1997 in the USA [12]. Nolan et al. [3] described that
most fatalities from NMSC in Western Australia were caused
by 1 of 3 neoplasms: SCC, Merkel cell carcinoma, and
adenosquamous carcinoma, and that the mortality rate for
NMSC was 0.8% under the stringent criteria of cancer-
related mortality except for cancers of the lip.
In 2000, Salasche [13] estimated that there were approx-
imately 200,000 new SCCs each year in the USA and
between 1,300 and 2,300 people died each year as a result
of NMSC, mostly metastatic SCC. In Australia, there were
nearly 400 deaths from NMSC annually [14]. And, the
majority of NMSC deaths were due to SCCs, had primary
sites associated with signiﬁcant sun exposure, and occurred
in older men [14]. There is no estimated incidence of NMSC
yet in Japan, although Ishihara [15] estimated 5,000 BCC
and 2,000–2,500 new SCC cases/year in 1994. The author
could not believe those ﬁgures which were estimated from
a survey in 75 university hospitals and 25 large hospitals.
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Figure 1: Annual trends in the number of deaths from non-
melanoma skin cancer (NMSC) in Japan (1955∼2008), modiﬁed
from Ohtsuka and Nagamatsu [7].
0
0.2
0.4
0.6
0.8
1.0
R
a
t
e
p
e
r
1
0
0
0
0
0
1955 1960
Total
Males
Females
1965 1970 1975
Year
1980 1985 1990 1995 2000 2005
Figure 2: Annual trends in age-standardized death rates of NMSC
in Japan (1955∼2008), modiﬁed from Ohtsuka and Nagamatsu
[7].
The author estimates that many NMSCs were excluded
from the statistics, because many of them were treated at
smaller hospitals or even at clinics. At least, a tenth to a
ﬁfth of 2 million NMSC cases/year/314.7 million population
in 2010 in the USA, that is, 200,000–400,000 new NMSC
cases/year/127.6 million population are estimated in 2010 in
Japan in due consideration of the diﬀerence between races
and/or between geographic distributions in the USA and
Japan.Journal of Skin Cancer 3
Table 1: The annual increased ratio of deaths from nonmelanoma skin cancer (NMSC) (% and 95% conﬁdence interval) from 3-year
moving average by sex in each ICD revision in Japan.
Revision (year) Males Females Total
ICD-6,7 (1955∼1967) −0.4 (−1.9∼1.0) 0.5 (−2.0∼2.9) 0.0 (−1.4∼1.4)
ICD-8 (1968∼1978) 0.1 (−1.2∼1.3) −0.2 (−2.9∼2.6) −0.1 (−1.8∼1.6)
ICD-9 (1979∼1994) −1.0 (−2.5∼0.5) −0.5 (−2.8∼1.9) −0.8 (−2.0∼0.4)
ICD-10 (1995∼2008) 2.9 (0.7∼5.1) 4.7 (3.1∼6.3) 3.8 (2.7∼4.9)
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Figure 3: Annual trends in three-year moving average of NMSC
in 1955–1967, 1968–1978, 1979–1994, and 1995–2008 in Japan,
modiﬁed from Ohtsuka and Nagamatsu [7].
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Figure 4: Annual trends in the number of deaths from NMSC
by age group in Japan (1955∼2008), modiﬁed from Ohtsuka and
Nagamatsu [7].
The development of surgical procedures may have a close
relationship with the decrease in the number of deaths from
NMSC after 1979 in Japan, in addition to minor changes
of ICD classiﬁcation. Many typical NMSCs developed in
injured or chronically diseased skin, including skin aﬀected
by long-standing ulcers and radiation dermatitis, could from
then on be treated completely by wide excisions, followed
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Figure 5: Annual trends in the number of deaths from NMSC by
sex and age group in Japan (1955∼2008), modiﬁed from Ohtsuka
and Nagamatsu [7].
by appropriate reconstructive procedures such as newly
developed free ﬂaps and pedicled or free musculocutaneous
ﬂaps in the 1970s [16, 17], resulting in a remarked reduction
in the number of deaths from NMSC in Japan [7]. The
new increase after 1995 in Japan may be explained ﬁrstly by
the increasing proportion of elderly subjects with an actinic
keratosis- (AK-) induced SCC in poor condition, secondly
by improvements in diagnosis, and thirdly by the greater
precision in reporting on death certiﬁcates from any cause
as associated with NMSC [7].4 Journal of Skin Cancer
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Figure 6:AnnualtrendsintheproportionofdeathsfromNMSCby
sex and age group in Japan (1955∼2008), modiﬁed from Ohtsuka
and Nagamatsu [7].
In Japan, the cause of death has been established from
death certiﬁcate. And, death certiﬁcates have been forwarded
through city or town oﬃce to Statistics and Information
Department of Ministry of Health, Labor and Welfare.
The validity and reliability of the data have been believed
to be suﬃciently trustworthy because the proportion of
histopathological diagnosis especially in malignant tumors
has increased remarkably year by year. The cause of death
has been analyzed every year since 1899 and has been used
for the analyses of many malignant tumors, according to
WHO ICD classiﬁcation. Stang and J¨ ockel [18]s u g g e s t e d
that a limitation of the NMSC mortality study results was
the potential inaccuracy of routine universal cause-of-death
certiﬁcation. The validity of cause-of-death certiﬁcation had
not been studied for NMSC in Germany.
Nevertheless, statistics based on routine death certiﬁca-
tion may provide a rough guide to the magnitude of NMSC
mortality. Girschik et al. [14] also stated that overall their
study found that misclassiﬁcation of skin cancer deaths in
Western Australia Cancer Registry was minimal with less
than 1% of cases miscoded.
The major strength of this paper is the large sample size
from which the data is drawn. In addition, it gives a very
recent analysis of the death rate from NMSC in Japan. On
the other hand, there still remains a limitation of the validity
and reliability of the cause of death in NMSC, in spite of
increasing ratio of histopathological diagnosis. Therefore,
retrospective study for the correlation between the cause of
death and histopathological diagnosis should sometimes be
performed to decrease the proportion of misclassiﬁcation or
histopathological misdiagnosis of skin cancer deaths by re-
examinations of histological sections.
In addition, another problem prohibiting from accuracy
of coding of the cause of death apart from histopathological
diagnosis might have arisen, or may gradually arise. The
cause of death may be misdiagnosed or miscoded as pneu-
monia, chronic lymphoid leukemia, death of old age with
dementia, and others, in spite of existence of invasive and
metastatic SCC, when the elderly may die at nursing homes
or even hospitals without biopsy or autopsy, and medical
personnel may be less familiar with NMSC, resulting in the
decreased number of death from NMSC. Hasuo et al. [19]
described that the validation of certiﬁed diagnosis was less
reliable in the aged population.
The population of Japan has not increased remarkably
in the last 30 years and has been rather plateaued to slightly
decreased in the last 10 years. However, proportion of the
elderly of 65 years and over has increased year by year,
reaching 23.1% (males: 20.3%, females: 25.8%) of total
population in 2010. Life expectancy at birth for females in
2010 was 86.44 years, which was the ﬁrst rank in the world,
and that for males was 79.59 years, the ﬁfth rank, according
to the Ministry of Health, Labor and Welfare in Japan.
The most important prevention via routine screening
and better treatment of the elderly can help identify
potential lethal lesions, improve prognosis, and reduce
deaths. Although there may always be the occasional very
elderly patient with multiple comorbid medical conditions
whose skin cancer can be more easily handled with simple
electrodesiccation and curettage, Mohs surgery does appear
tobeasafeandeﬀectivetherapyforthegreatmajorityofvery
elderly patients in the USA [20, 21].
5. Conclusions
Theauthorrightlyemphasizedbasedonhisdataanalysisthat
the elderly had increased risk of death from NMSC. In recent
years, more than 50% of the deaths among females occurred
atorafter85yearsofageandthecorrespondingageformales
was at or after 75 years, nearly reaching at or after 80 years
of age. The most important prevention via routine screening
andbettertreatmentoftheelderlycanhelpidentifypotential
lethal lesions, improve prognosis, and reduce deaths.
Acknowledgment
The author acknowledge the permission to use the Figures
1 to 6, which were appeared in our article “Ohtsuka and
Nagamatsu [7],” under the kindness of S. Karger AG MedicalJournal of Skin Cancer 5
and Scientiﬁc Publishers, Basel, Switzerland, although, this
time, each ﬁgure was expanded up to 2008 from 2000 and
depicted newly.
References
[1] A. Hannuksela-Svahn, E. Pukkala, and J. Karvonen, “Basal
cell skin carcinoma and other nonmelanoma skin cancers in
Finland from 1956 through 1995,” Archives of Dermatology,
vol. 135, no. 7, pp. 781–786, 1999.
[2] M. Alam and D. Ratner, “Cutaneous squamous-cell carci-
noma,” New England Journal of Medicine, vol. 344, no. 13, pp.
975–983, 2001.
[3] R. C. Nolan, M. T. L. Chan, and P. J. Heenan, “A clinicopatho-
logic review of lethal nonmelanoma skin cancers in Western
Australia,” Journal of the American Academy of Dermatology,
vol. 52, no. 1, pp. 101–108, 2005.
[ 4 ]A .C .H a l p e r na n dL .J .K o p p ,“ A w a r e n e s s ,k n o w l e d g ea n d
attitudes to non-melanoma skin cancer and actinic keratosis
among the general public,” International Journal of Dermatol-
ogy, vol. 44, no. 2, pp. 107–111, 2005.
[ 5 ]E .d eV r i e s ,L .V .v a nd eP o l l - F r a n s e ,W .J .L o u w m a n ,F .R .
de Gruijl, and J. W. W. Coebergh, “Predictions of skin cancer
incidence in the Netherlands up to 2015,” British Journal of
Dermatology, vol. 152, no. 3, pp. 481–488, 2005.
[6] E. W. Ek, F. Giorlando, S. Y. Su, and T. Dieu, “Clinical
diagnosis of skin tumours: how good are we?” ANZ Journal
of Surgery, vol. 75, no. 6, pp. 415–420, 2005.
[7] H. Ohtsuka and S. Nagamatsu, “Changing trends in the
number of deaths from nonmelanoma skin cancer in Japan,
1955–2000,” Dermatology, vol. 210, no. 3, pp. 206–210, 2005.
[8] O. B. Ahmad, C. Boschi-Pinto, A. D. Lopez, C. J. L. Murray,
R. Lozano, and M. Inoue, “A new WHO standard population
(Table 4). Age standardization of rates: a new WHO stan-
dard,” GPE Discussion Paper 31, 2005, http://w3.whosea.org/
healthreport/pdf/paper31.pdf.
[9] A. Jemal, R. Siegel, J. Xu, and E. Ward, “Cancer statistics,
2010,” CACancerJournalforClinicians,vol.60,no.5,pp.277–
300, 2010.
[10] A. C. Halpern and L. J. Hanson, “Awareness of, knowledge
of and attitudes to nonmelanoma skin cancer (NMSC)
and actinic keratosis (AK) among physicians,” International
Journal of Dermatology, vol. 43, no. 9, pp. 638–642, 2004.
[11] S. P. Stratton, “Prevention of non-melanoma skin cancer,”
Current Oncology Reports, vol. 3, no. 4, pp. 295–300, 2001.
[12] M. A. Weinstock, “Death from skin cancer among the elderly:
epidemiological patterns,” Archives of Dermatology, vol. 133,
no. 10, pp. 1207–1209, 1997.
[13] S. J. Salasche, “Epidemiology of actinic keratoses and squa-
mous cell carcinoma,” Journal of the American Academy of
Dermatology, vol. 42, no. 1, part 2, pp. S4–S7, 2000.
[14] J. Girschik, L. Fritschi, T. Threlfall, and T. Slevin, “Deaths
fromnon-melanomaskincancerinWesternAustralia,”Cancer
Causes and Control, vol. 19, no. 8, pp. 879–885, 2008.
[15] K. Ishihara, “Nationwide survey of malignant skin tumors in
Japan,”SkinCancer,vol.9(Specialissue):7–14,pp.72–77,1994
(Japanese).
[16] S. Tamai, “History of microsurgery,” Plastic and Reconstructive
Surgery, vol. 124, supplement 6, pp. 282e–294e, 2009.
[17] S. Tamai, “Erratum: history of microsurgery (Plastic and
ReconstructiveSurgery(2009)124:6S282e–294e),”Plasticand
Reconstructive Surgery, vol. 125, no. 3, p. 1050, 2010.
[18] A. Stang and K. H. J¨ ockel, “Declining mortality rates for non-
melanoma skin cancers in West Germany, 1968–99,” British
Journal of Dermatology, vol. 150, no. 3, pp. 517–522, 2004.
[19] Y. Hasuo, K. Ueda, Y. Kiyohara et al., “Accuracy of diagnosis
on death certiﬁcates for underlying causes of death in a long-
term autopsy-based population study in Hisayama, Japan;
with special reference to cardiovascular diseases,” Journal of
Clinical Epidemiology, vol. 42, no. 6, pp. 577–584, 1989.
[20] J. C. Pascual, I. Belinch´ o n ,J .M .R a m o s ,M .B l a n e s ,a n dI .
Betlloch, “Skin tumors in patients aged 90 years and older,”
Dermatologic Surgery, vol. 30, no. 7, pp. 1017–1019, 2004,
’Commentary’ by MacFarlane D. F. 1019–1020.
[21] L. Cumberland, A. Dana, and N. Liegeois, “Mohs micro-
graphic surgery for the management of nonmelanoma skin
cancers,” Facial Plastic Surgery Clinics of North America, vol.
17, no. 3, pp. 325–335, 2009.